Regular Paper
Matrix metalloproteinases and tumor invasion: from correlation and causality to the clinic

https://doi.org/10.1006/scbi.1996.0020Get rights and content

Abstract

Tumor cell invasion is now viewed as dysregulated physiologic invasion. Investigators have started to define the molecular events that are involved in this process. We find that there are many functional similarities with molecular events involved in physiologic process such as angiogenesis and wound healing. Matrix metalloproteinase activity is a common denominator in these pathologic conditions and in normal responses. Studies using endogenous metalloproteinase inhibitors suggest that targeting matrix metalloproteinase activity may prevent tumor cell dissemination. The development and pre-clinical testing of novel, low molecular weight matrix metalloproteinase inhibitors support this concept and suggest that an exciting new era of cancer therapy is on the horizon.

References (0)

Cited by (343)

  • Nutraceuticals in cancer prevention

    2021, Nutraceuticals: Efficacy, Safety and Toxicity
  • Mitigation of arsenic-induced acquired cancer phenotype in prostate cancer stem cells by miR-143 restoration

    2016, Toxicology and Applied Pharmacology
    Citation Excerpt :

    However, upon miR-143 overexpression in these As-CSC cells, there was a marked inhibition of MMP-9 and MMP-2 activities. Considering the important roles of MMPs in carcinogenesis as modulators of the tumor microenvironment (Bachmeier et al., 2000; Kessenbrock et al., 2010; Radisky and Radisky, 2010; Stetler-Stevenson et al., 1996), the observed decrease in MMP-9 and MMP-2 activities in response to miR-143 overexpression is indicative of a diminished cancer phenotype in the As-CSCs. The ability of cancer cells to expand in number is dependent on both the rate of cell proliferation and cell death, mainly by apoptosis.

  • Proteases in cancer drug delivery

    2016, Advanced Drug Delivery Reviews
  • How to tackle protein structural data from solution and solid state: An integrated approach

    2016, Progress in Nuclear Magnetic Resonance Spectroscopy
    Citation Excerpt :

    Most MMPs comprise a prodomain that is removed upon activation, a catalytic domain responsible for hydrolytic activity, and a hemopexin-like domain that probably plays a role in substrate recognition. In several pathologies, overexpression of MMPs, or misregulation of their activity, is related to disease progression [173–175]. MMPs are thus validated pharmaceutical targets.

View all citing articles on Scopus
View full text